Abstract. A five-year-old Japanese boy with hepatomegaly and muscle weakness due to hepatic phosphorylase kinase deficiency is described. He was also found to have short stature ( -2.94 SD). We revealed the presence of mild hypoglycemia, marked ketosis and insufficiency of physiological growth hormone secretion during nighttime. Serum total and free carnitine levels were low and the acyl to total carnitine ratio was high. Urinary acylcarnitine profile by fast atom bombardment and tandem mass spectrometry showed elevated levels of acetyl and dicarboxy carnitines.
growth hormone secretion during nighttime.
Serum total and free carnitine levels were low and the acyl to total carnitine ratio was high. Urinary acylcarnitine profile by fast atom bombardment and tandem mass spectrometry showed elevated levels of acetyl and dicarboxy carnitines.
Uncooked cornstarch (2 g/kg) was given every night for one month. The metabolic and endocrinological abnormalities were improved by uncooked cornstarch treatment. Uncooked cornstarch (UCC) (2 g/kg) was given at 21:00 every night for 1 month. Nighttime blood sugar, ketone bodies, and GH secretion were examined before and after UCC treatment.
Blood samples were collected at 22:00, 1:00, 4:00 and 7:00 for blood sugar and ketone bodies, and every 20 min after sleep for 3 hours for GH profiling.
Acylcarnitine in plasma and urine was determined by fast atom bombardment and tandem mass spectrometry (FAB-MS/MS) [2] .
Results
The levels of blood sugar before UCC Table 2 . Endocrinological data (CA 4y5m) treatment decreased slightly during nighttime, while those of ketone bodies markedly increased.
The peak of GH before UCC treatment was low (7.9 ng/ml) and the mean concentration of GH was 4.4 ng/ml. After one month of UCC treatment, nighttime blood sugar levels slightly increased and the ketone bodies were markedly reduced.
Two significant GH peaks were recognized and the mean GH concentration also increased to 10.6 ng/ml (Figure 1) .
Before treatment, serum levels of free and total carnitine were low, and the acyl to total carnitine ratio was 0.29 (Table 3) . During UCC treatment, levels of free land total carnitine were normalized, and the acyl/total carnitine ratio decreased to 0.13. Urinary excretion of acylcarnitine decreased and that of free carnitine increased. Mass spectra of urinary acylcarnitine before UCC treatment 
